Our study revealed that NAT10 expression was associated with tumor stage, lymph node metastasis, vascular invasion and distant metastasis in patients with CRC and a higher NAT10 expression level implied a poorer prognosis. Here, NAT10 is linked to metastatic malignant neoplasm in the lymph nodes.